Want to see DE:LIK full AI Analyst Report?

Limes Schlosskliniken AG (LIK) Price & Analysis

3 Followers

LIK Stock Chart & Stats

€565.00

-€10.00(-1.77%)

At close: Jul 27 4:00 PM EDT

€565.00

-€10.00(-1.77%)

Day’s Range― - ―

52-Week Range€316.00 - €590.00

Previous CloseN/A

Volume35.00

Average Volume (3M)37.00

Market Cap

€171.00M

Enterprise Value€150.88M

Total Cash (Recent Filing)€10.31M

Total Debt (Recent Filing)€10.73M

Price to Earnings (P/E)30.1

Beta-0.05

Next Earnings

Aug 31, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.74%

Share Statistics

EPS (TTM)19.29

Shares Outstanding300,000

10 Day Avg. Volume27

30 Day Avg. Volume37

Financial Highlights & Ratios

PEG Ratio0.23

Price to Book (P/B)4.17

Price to Sales (P/S)2.11

P/FCF Ratio142.49

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)31.18

Revenue Forecast (FY)€66.40M

Bulls Say, Bears Say

Bulls Say

Sustained Top-line GrowthConsistent high revenue growth demonstrates durable demand for LIK's private specialist clinic services and supports scaling of operations. Over 2–6 months this underpins capacity expansion, better utilization of fixed costs, and stronger strategic positioning within Germany's private healthcare segment.

Consistent Operating ProfitabilitySustained profitability and positive EBIT/EBITDA across recent years indicate the business model produces recurring operating earnings. This durability supports internal funding for investments, reduces reliance on external financing, and provides a buffer against cyclical pressures in patient volumes or reimbursement.

Improving Balance Sheet And Moderate LeverageA strengthening equity base and more moderate leverage relative to prior years enhance financial resilience. Improved balance sheet scale gives LIK flexibility for targeted investments or acquisitions, lowers solvency risk during downturns, and supports multi-month planning for capacity and service expansion.

Bears Say

Uneven Free Cash Flow / Cash ConversionVolatile free cash flow reduces the company's ability to sustainably self-fund capex, pay dividends, or deleverage. Over a multi-month horizon, weak cash conversion raises refinancing and liquidity risk if operating inflows weaken, and constrains strategic flexibility for investments or margin-supporting initiatives.

Margin Volatility And Profitability ConsistencySignificant swings in gross and net margins suggest earnings are sensitive to mix, accounting timing, or one-off effects. This undermines predictable earnings power and complicates long-term planning, making sustained margin improvement and reliable cash generation harder to assume in the medium term.

Meaningful Absolute Debt LevelWhile leverage is moderate, the absolute debt burden can still pressure cash flows if revenues or margins slip. Coupled with volatile FCF and margins, existing debt raises refinancing and interest-service risk over several months, potentially limiting capital allocation to growth or margin-improvement projects.

LIK FAQ

What was Limes Schlosskliniken AG’s price range in the past 12 months?

Limes Schlosskliniken AG lowest stock price was €316.00 and its highest was €590.00 in the past 12 months.

What is Limes Schlosskliniken AG’s market cap?

Limes Schlosskliniken AG’s market cap is €171.00M.

When is Limes Schlosskliniken AG’s upcoming earnings report date?

Limes Schlosskliniken AG’s upcoming earnings report date is Aug 31, 2026 which is in 16 days.

How were Limes Schlosskliniken AG’s earnings last quarter?

Limes Schlosskliniken AG released its earnings results on May 11, 2026. The company reported €7.993 earnings per share for the quarter, beating the consensus estimate of N/A by €7.993.

Is Limes Schlosskliniken AG overvalued?

According to Wall Street analysts Limes Schlosskliniken AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Limes Schlosskliniken AG pay dividends?

Limes Schlosskliniken AG pays a Notavailable dividend of €10 which represents an annual dividend yield of 1.74%. See more information on Limes Schlosskliniken AG dividends here

What is Limes Schlosskliniken AG’s EPS estimate?

Limes Schlosskliniken AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Limes Schlosskliniken AG have?

Limes Schlosskliniken AG has 300,000 shares outstanding.

What happened to Limes Schlosskliniken AG’s price movement after its last earnings report?

Limes Schlosskliniken AG reported an EPS of €7.993 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.225%.

Which hedge fund is a major shareholder of Limes Schlosskliniken AG?

Currently, no hedge funds are holding shares in DE:LIK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Limes Schlosskliniken AG Stock Smart Score

Neutral

Insider Transactions

Sold Shares

Worth €3.3M over
the Last 3 Months

Technicals

Fundamentals

Return on Equity

1.74%

Trailing 12-Months

Asset Growth

17.15%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Limes Schlosskliniken AG

LIMES Schlosskliniken AG oversees private healthcare facilities specializing in psychiatric, psychotherapeutic, and psychosomatic treatments. The organization primarily concentrates on addressing conditions arising from stress, alongside a variety of psychological and emotional disorders such as depression, severe burnout, mood disorders, and trauma. Headquartered in Cologne, Germany, LIMES Schlosskliniken AG operates as a subsidiary of GMF Capital GmbH.